Literature DB >> 31685965

Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).

M Varma1, J R Srigley2, F Brimo3, E Compérat4, B Delahunt5, M Koch6, A Lopez-Beltran7, V Reuter8, H Samaratunga9,10,11, J H Shanks12, T Tsuzuki13, T van der Kwast14, F Webster15, D Grignon16.   

Abstract

The International Collaboration on Cancer Reporting (ICCR) is an alliance of major pathology organisations in Australasia, Canada, Europe, United Kingdom, and United States of America that develops internationally standardised, evidence-based datasets for the pathology reporting of cancer specimens. This dataset was developed by a multidisciplinary panel of international experts based on previously published ICCR guidelines for the production of cancer datasets. It is composed of Required (core) and Recommended (noncore) elements identified on the basis of literature review and expert consensus. The document also includes an explanatory commentary explaining the rationale behind the categorization of individual data items and provides guidance on how these should be collected and reported. The dataset includes nine required and six recommended elements for the reporting of cancers of the urinary tract in biopsy and transurethral resection (TUR) specimens. The required elements include specimen site, operative procedure, histological tumor type, subtype/variant of urothelial carcinoma, tumor grade, extent of invasion, status of muscularis propria, noninvasive carcinoma, and lymphovascular invasion (LVI). The recommended elements include clinical information, block identification key, extent of T1 disease, associated epithelial lesions, coexistent pathology, and ancillary studies. The dataset provides a structured template for globally harmonized collection of pathology data required for management of patients diagnosed with cancer of the urinary tract in biopsy and TUR specimens. It is expected that this will facilitate international collaboration, reduce duplication of effort in updating current national/institutional datasets, and be particularly useful for countries that have not developed their own datasets.

Entities:  

Year:  2019        PMID: 31685965     DOI: 10.1038/s41379-019-0403-9

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  3 in total

Review 1.  Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.

Authors:  Eva Compérat; André Oszwald; Gabriel Wasinger; Donna E Hansel; Rodolfo Montironi; Theodorus van der Kwast; Johannes A Witjes; Mahul B Amin
Journal:  World J Urol       Date:  2021-09-23       Impact factor: 3.661

2.  T1 bladder carcinoma with variant histology: pathological features and clinical significance.

Authors:  Antonio Lopez-Beltran; Ana Blanca; Alessia Cimadamore; Rodolfo Montironi; Rafael J Luque; Metka Volavšek; Liang Cheng
Journal:  Virchows Arch       Date:  2022-02-04       Impact factor: 4.535

Review 3.  Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View.

Authors:  Roberta Mazzucchelli; Daniela Marzioni; Giovanni Tossetta; Laura Pepi; Rodolfo Montironi
Journal:  Front Surg       Date:  2021-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.